Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Anthem and Memorial Sloan Kettering Cancer Center reach a deal ensuring continued in-network care for Anthem-insured cancer ...

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

BOULDER, Colo., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics (Foresight), a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today provided its strategic ...

Ann Graham of MIB Agents discussed some of the challenges adolescent and young adult patients deal with after cancer ...

NATICK, Mass., Jan. 7, 2025 /PRNewswire/ -- Pillar Biosciences, Inc. has entered into a strategic five-year licensing ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...